Royalty asks to set appeal for next week
US-based Royalty Pharma is planning to appeal a recent ruling from the Irish takeover panel, which if left unchallenged, could force them to withdraw their most recent $8bn offer for...
US-based Royalty Pharma is planning to appeal a recent ruling from the Irish takeover panel, which if left unchallenged, could force them to withdraw their most recent $8bn offer for...